Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹11 Cr₹5.22 Cr₹5.83 Cr₹-25 Cr₹-20 Cr

What is the latest Consolidated Net Profit of BAFNA PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BAFNA PHARMACEUTICALS is ₹11 Cr based on Mar2023 Standalone results.
Year Consolidated Net Profit
Mar2023₹11 Cr
Mar2022₹5.22 Cr
Mar2021₹5.83 Cr
Mar2020₹-25 Cr
Mar2019₹-20 Cr

How is Consolidated Net Profit of BAFNA PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹11 Cr
117.33
Mar2022 ₹5.22 Cr
-10.47
Mar2021 ₹5.83 Cr
Positive
Mar2020 ₹-25 Cr
Negative
Mar2019 ₹-20 Cr -

Compare Consolidated Net Profit of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹253.0 Cr 16.9% 31.2% -1.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹115,034.0 Cr 1% -5% 53.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.1% 2.2% 26% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr 3.2% 15.3% 23.6% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 3.9% -1.7% 85.2% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

16.9%

31.2%

-1.1%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses